References
- Bari MF, Brown H, Nicholson AG, et al. BAI3, CDX2 and VIL1: A panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas. Histopathology 2014;64:547–56.
- Spano JP, Andre F, Morat L, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 2004;15:613–7.
- Nielsen CK, Campbell JIA, Öhd JF, John FO. A novel localization of the G-protein-coupled CysLT 1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 2005;3:732–42.
- Wang N, Wu QL, Fang Y, et al. Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. J Transl Med 2005;3:26.
- Davies JQ, Lin HH, Stacey M, et al. Leukocyte adhesion-GPCR EMR2 is aberrantly expressed in human breast carcinomas and is associated with patient survival. Oncol Rep 2011;25:619–27.
- Pierce KL, Premont RT, Lefkowitz RJ, Hughes TH. Seven-transmembrane receptors. Nat Rev 2002;3:639–50.
- Flower DR. Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta - Rev Biomembr 1999;1422:207–34.
- Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer [Internet]. 2007;7:79–94. Available from: http://www.nature.com/doifinder/10.1038/nrc2069
- Choi HY, Saha SK, Kim K, et al. G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells. BMB Rep 2015;48:68–80.
- Wise H, Jupe S, Rees S. The identification of ligands at orphan G-protein coupled receptors. Annu Rev Pharmacol Toxicol [Internet]. 2004;44:43–66. Available from: http://www.annualreviews.org/doi/10.1146/annurev.pharmtox.44.101802.121419
- Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258–64.
- Heasley LE. Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 2001;20:1563–9.
- Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005;146:624–32.
- Marinissen MJ, Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci [Internet]. 2001;22:368–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11431032
- Sonoshita M, Takaku K, Sasaki N, et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice. Nat Med [Internet]. 2001;7:1048–51. Available from: http://www.nature.com/nm/journal/v7/n9/full/nm0901-1048.html%5Cnhttp://www.nature.com/nm/journal/v7/n9/pdf/nm0901-1048.pdf
- Castellone MD, Teramoto H. Prostaglandin E 2 promotes colon cancer cell growth through a G s-axin-b-catenin signaling axis. 2005;310:1504–10.
- Balkwill F. Cancer and the chemokine network. Nat Rev Cancer [Internet]. 2004;4:540–50. Available from: http://www.nature.com/doifinder/10.1038/nrc1388
- Staller P, Sulitkova J, Lisztwan J, et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003;425:307–11.
- Müller a, Müller A, Homey B, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature [Internet]. 2001;410:50–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11242036
- Sternlicht M, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu REv Cell Biol 2009;17:463–516.
- Ohtaki T, Shintani Y, Honda SI, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001;411:613–7.
- Richard DE, Vouret-Craviari V, Pouysségur J. Angiogenesis and G-protein-coupled receptors: signals that bridge the gap. Oncogene 2001;20:1556–62.
- Salcedo R, Oppenheim JJ. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation [Internet]. 2003;10:359–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12851652
- Strieter RM, Burdick MD, Mestas J, et al. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006;42:768–78.
- Fredriksson R, Lagerström MC, Lundin L, Schiöth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003;63:1256–72.
- Ross EM, Wilkie TM. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000;69:795–827.
- Michiel H, Krans J, Diseases M, The of Rat Liver Adenyl Cyclase System in Plasma Membranes. 1971.
- Zheng B, Ma YC, Ostrom RS, et al. RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. Science [Internet]. 2001;294:1939–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11729322
- Ma YC, Huang J, Ali S, et al. Src tyrosine kinase is a novel direct effector of G proteins. Cell 2000;102:635–46.
- Kwok-Keung Fung B, Stryer L. Photolyzed rhodopsin catalyzes the exchange of GTP for bound GDP in retinal rod outer segments. Proc Natl Acad Sci USA [Internet]. 1980;77:2500–4. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=349428&tool=pmcentrez&rendertype=abstract
- Meng J, Glick JL, Polakis P, Casey PJ. Functional interaction between Gαz and Rap1GAP suggests a novel form of cellular cross-talk. J Biol Chem 1999;274:36663–9.
- Chikumi H, Vázquez-Prado J, Servitja JM, et al. Potent activation of RhoA by Galpha q and Gq-coupled receptors. J Biol Chem 2002;277:27130–4.
- Meigs TE, Fields TA, McKee DD, Casey PJ. Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta -catenin release. Proc Natl Acad Sci USA [Internet]. 2001;98:519–24. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14619&tool=pmcentrez&rendertype=abstract
- Boyer JL, Waldo GL, Harden TK. Beta gamma-subunit activation of G-protein-regulated phospholipase C. J Biol Chem 1992;267:25451–6.
- Stephens L, Smrcka A, Cooke FT, et al. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. Cell [Internet]. 1994;77:83–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8156600
- Araç D, Boucard A. a, Bolliger MF, et al. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis. Embo J 2012;31:1364–78.
- Manuscript A, Syndromes GP, NIH Public Access. 2010;48(Suppl2):1–6.
- Bjarnadóttir TK, Geirardsdóttir K, Ingemansson M, et al. Identification of novel splice variants of adhesion G protein-coupled receptors. Gene 2007;387:38–48.
- Langenhan T, Aust G, Hamann J. Sticky signaling — adhesion class G protein – coupled receptors take the stage. Science Signaling 2013;6:1–22.
- Iguchi T, Sakata K, Yoshizaki K, et al. Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway. J Biol Chem [Internet]. 2008;283:14469–78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18378689
- SM C. Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumour development. J Mol Med (Berl) 2011;89:743–52.
- Boutin C, Goffinet AM, Tissir F. Celsr1-3 cadherins in PCP and brain development. Curr Top Dev Biol 2012;101:161–83.
- Usui T, Shima Y, Shimada Y, et al. Flamingo, a seven-pass transmembrane cadherin, regulates planar cell polarity under the control of Frizzled. Cell 1999;98:585–95.
- Li X, Roszko I, Sepich DS, et al. Gpr125 modulates dishevelled distribution and planar cell polarity signaling. Development [Internet]. 2013;140:3028–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23821037
- Langenhan T, Pr??mel S, Mestek L, et al. Latrophilin signaling links anterior-posterior tissue polarity and oriented cell divisions in the C.elegans embryo. Dev Cell 2009;17:494–504.
- Haitina T, Olsson F, Stephansson O, et al. Expression profile of the entire family of sdhesion G protein-coupled receptors in mouse and rat. BMC Neurosci 2008;9:43.
- Cork SM, Van Meir EG. Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development. J Mol Med 2011;89:743–52.
- Shima Y, Kawaguchi S, Kosaka K, et al. Opposing roles in neurite growth control by two seven-pass transmembrane cadherins. Nat Neurosci 2007;10:963–9.
- Cullen M, Elzarrad MK, Seaman S, et al. GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc Natl Acad Sci USA [Internet]. 2011;108:5759–64. Available from: http://www.pnas.org/content/108/14/5759.short
- Karpus ON, Veninga H, Hoek RM, et al. Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55. J Immunol [Internet]. 2013;190:3740–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23447688
- Seandel M, James D, Shmelkov SV, et al. Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature 2007;449:346–50.
- Xu L, Begum S, Hearn JD, Hynes RO. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 2006;103:9023–8.
- Shashidhar S, Lorente G, Nagavarapu U, et al. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 2005;24:1673–82.
- Tang X, Jin R, Qu G, et al. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway. Cancer Res [Internet]. 2013;73:6206–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24008316
- Lum AM, Wang BB, Beck-Engeser GB, et al. Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer. BMC Cancer 2010;10:40.
- Fu JF, Yen TH, Chen Y, et al. Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model. Int J Cancer 2013;133:1792–802.
- Vallon M, Essler M. Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin αvβ3 to glycosaminoglycans. J Biol Chem 2006;281:34179–88.
- Aust G, Steinert M, Schütz A, et al. CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas. Am J Clin Pathol 2002;118:699–707.
- Steinert M, Wobus M, Boltze C, et al. Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am J Pathol 2002;161:1657–67.
- Mustafa T, Eckert A, Klonisch T, et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin. Cancer Epidemiol Biomarkers Prev 2005;15:2145–50.
- Ward Y, Lake R, Yin JJ, et al. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells. Cancer Res 2011;71:7301–11.
- Shiratsuchi T, Nishimori H, Ichise H, et al. Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1). Cytogenet Cell Genet [Internet]. 1997;79:103–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9533023
- Kan Z, Jaiswal BS, Stinson J, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010;466:869–73.
- Kaur B, Brat DJ, Devi NS, Van Meir EG. Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene 2005;24:3632–42.
- Okajima D, Kudo G, Yokota H. Brain-specific angiogenesis inhibitor 2 (BAI2) may be activated by proteolytic processing. J Recept Signal Transduct Res 2010;30:143–53.
- Bolliger MF, Martinelli DC, Südhof TC. The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins. Proc Natl Acad Sci USA [Internet]. 2011;108:2534–9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3038708&tool=pmcentrez&rendertype=abstract
- DeRosse P, Lencz T, Burdick KE, et al. The genetics of symptom-based phenotypes: Toward a molecular classification of schizophrenia. Schizophr. Bull 2008;34:1047–53.
- De Fraipont F, Nicholson AC, Feige JJ, Van Meir EG. Thrombospondins and tumor angiogenesis. Vol. 7. Trends Mol Med 2001;7:401–7.
- Jimenez B, Volpert OV, Reiher F, et al. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Oncogene [Internet]. 2001;20:3443–8. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11423995
- Gupta K, Gupta P. Binding and displacement of vascular endothelial growth factor (VEGF). Angiogenesis 1999;3:147–58.
- Reiher FK, Volpert OV, Jimenez B, et al. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. Int J Cancer 2002;98:682–9.
- Shiratsuchi T, Oda K, Nishimori H, et al. Cloning and characterization of BAP3 (BAI-associated protein 3), a C2 domain-containing protein that interacts with BAI1. Biochem Biophys Res Commun 1998;251:158–65.
- Fujiwara T, Mammoto A, Kim Y, Takai Y. Rho small G-protein-dependent binding of mDia to an Src homology 3 domain-containing IRSp53/BAIAP2. Biochem Biophys Res Commun [Internet]. 2000;271:626–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10814512
- Koh JT, Leel ZH, Ahn KY, et al. Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein. Brain Res. Mol. Brain Res 2001;87:223–37.
- Lim IA, Hall DD, Hell JW. Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102. J Biol Chem 2002;277:21697–711.
- Fukushima Y, Oshika Y, Tsuchida T, et al. Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer. Int J Oncol [Internet]. 1998;13:967–70. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9772287
- Hatanaka H, Oshika Y, Abe Y, Yoshida Y, Hashimoto T, Handa A, etet al. Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1). Int J Mol Med 2000;5:181–3.
- Miyamoto N, Yamamoto H, Taniguchi H, et al. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability. Cancer Lett 2007;254:42–53.
- Gobeil F, Fortier A, Zhu T, et al. G-protein-coupled receptors signaling at the cell nucleus: an emerging paradigm This paper is one of a selection of papers published in this special issue, entitled The Nucleus: A Cell Within A Cell. Can J Physiol Pharmacol [Internet]. 2006;84:287–97. Available from: http://www.nrcresearchpress.com/doi/abs/10.1139/y05-127
- Christophe D, Christophe-Hobertus C, Pichon B. Nuclear targeting of proteins: how many different signals?. Cell Signal [Internet]. 2000;12:337–41. Available from: http://www.sciencedirect.com/science/article/pii/S0898656800000772
- Lee DK, Lança AJ, Cheng R, et al. Agonist-independent nuclear localization of the apelin, angiotensin AT 1, and bradykinin B2 receptors. J Biol Chem 2004;279:7901–8.
- Teasdale RD, Jackson MR. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the Golgi apparatus. Annu Rev Cell Dev Biol 1996;12:27–54.
- Joun H, Lanske B, Karperien M, et al. Tissue-specific transcription start sites and alternative splicing of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene: a new PTH/PTHrP receptor splice variant that lacks the signal peptide. Endocrinology 1997;138:1742–9.